Medical device that signals lumen loss

• US 8,048,141 B2
• Filed: 12/07/2004
• Issued: 11/01/2011
• Est. Priority Date: 12/07/2004
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Inventors: Stinson, Jonathan S.
• Primary Examiner(s): Isabella; David
• Assistant Examiner(s): Stroud; Jonathan R
• Application Number:
  US11/006,018
• Publication Number:
  US 20060122683A1
• Time in Patent Office: 2,520 Days
• Field of Search: 600/486, 600/481, 600/505, 600/553, 600/587, 604/890.1, 361/628
• US Class Current: 623/1.15
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2002/91525 within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
• CPC Class Codes: A61F 2002/91533 characterised by the phase between adjacent bands
• CPC Class Codes: A61F 2002/91558 connected peak to peak
• CPC Class Codes: A61F 2002/91566 connected trough to trough
• CPC Class Codes: A61F 2250/0002 for data transfer

Abstract

Embodiments of the present invention relate to medical devices that provide signals to diagnostic equipment such that functionality of an implantable member can be determined. In particular, various designs and structures are utilized to signal tissue growth on an implantable member such as a stent. The tissue growth can limit flow through the stented lumen. If the growth has a thickness above a certain limit, a signal can be detected by diagnostic equipment such that a proper diagnosis can be made.

Claims

1. A stent, comprising:

a structural element; and

a signaling member coupled to the structural element to signal a level of tissue growth on the structural element, where the signaling member includes a conductive pathway having a switch including a flowable filler material, where the switch closes in response to the level of tissue growth to provide a closed loop electrical pathway on the structural element and the switch includes a cover extending from an outer edge of the conductive pathway to an outer edge of the switch defining an area completely enclosed by the cover where the flowable filler material travels through a portion of the area completely enclosed by the cover to contact the conductive pathway forming the closed loop electrical pathway, where the cover prevents any tissue formation in the area completely enclosed by the cover.

2. The stent of claim 1, wherein the cover prevents any tissue formation that inhibits travel of the switch.

3. The stent of claim 1 wherein the flowable filler material is conductive and closes the conductive pathway in response to the level of tissue growth on the structural element.

4. The stent of claim 1 wherein the structural element comprises a generally tubular structure.

5. The stent of claim 4 wherein the generally tubular structure includes electrically conductive structural members spaced apart by nonconductive spacers and wherein the signaling member includes a switch that is adapted to electrically couple the electrically conductive structural members in response to the level of tissue growth.

6. The stent of claim 4, wherein the signaling member comprises a plurality of electrically conductive members extending from an inside surface of the tubular structure.

7. The stent of claim 1 wherein the signaling member includes at least one of platinum, iridium, tantalum, titanium, niobium, hafnium and gold.

8. The stent of claim 1 wherein the signaling member includes a pressure sensitive coating having a piezoelectric material.

9. The stent of claim 1 wherein the signaling member includes an elutable material.

10. The stent of claim 9 wherein the elutable material is a radiopaque coating.

11. The stent of claim 9 wherein the elutable material is a chemical that is detectable in a blood test.

12. The stent of claim 9 wherein the elutable material forms part of the structural element.

13. A stent, comprising:

a generally tubular structure, where the generally tubular structure includes a conductive pathway having a switch including a flowable filler material, where the switch closes in response to a level of tissue growth to provide a closed loop electrical pathway on the generally tubular structure, and a cover extending from an outer edge of the conductive pathway to an outer edge of the switch to define an area completely enclosed by the cover such that the switch travels through a portion of the area completely enclosed by the cover to form the closed loop electrical pathway, where the cover prevents tissue formation in the area completely enclosed by the cover.

14. The stent of claim 13 wherein the generally tubular structure includes electrically conductive structural members spaced apart by nonconductive spacers and wherein the switch is adapted to electrically couple the electrically conductive structural members in response to the level of tissue growth.

15. The stent of claim 13 wherein the generally tubular structure includes at least one of platinum, iridium, tantalum, titanium, niobium, hafnium and gold.

16. The stent of claim 13, wherein the generally tubular structure includes a plurality of electrically conductive members extending from an inside surface of the tubular structure.

17. The stent of claim 13 wherein the generally tubular structure includes a pressure sensitive coating having a piezoelectric material.

18. The stent of claim 13 wherein the generally tubular structure includes an elutable material.

19. The stent of claim 18 wherein the elutable material is a radiopaque coating.

20. The stent of claim 18 wherein the elutable material is a chemical that is detectable in a blood test.

21. The stent of claim 18 wherein the elutable material forms part of the generally tubular structure.